151671-10-2 Usage
General Description
Tetraethyl(3-hydroxypropylidene)bisphosphonate is a synthetic chemical compound that belongs to the class of bisphosphonates. It is a potent inhibitor of bone resorption and has been used as a treatment for bone disorders such as osteoporosis and Paget's disease. Tetraethyl(3-hydroxypropylidene)bisphosphonate works by inhibiting the activity of osteoclasts, the cells responsible for breaking down bone tissue. It also has the ability to bind to the bone mineral matrix, which helps to increase bone density and strength. Additionally, it has also been used in the treatment of certain types of cancers that have spread to the bone, as it can help to reduce bone pain and prevent fractures.
Check Digit Verification of cas no
The CAS Registry Mumber 151671-10-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,6,7 and 1 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 151671-10:
(8*1)+(7*5)+(6*1)+(5*6)+(4*7)+(3*1)+(2*1)+(1*0)=112
112 % 10 = 2
So 151671-10-2 is a valid CAS Registry Number.
151671-10-2Relevant articles and documents
PHOSPHONATE CONJUGATES AND USES THEREOF
-
Paragraph 00145, (2020/07/31)
Phosphonate conjugates, preferably, bisphosphonate conjugates; methods of inhibiting Ron receptor tyrosine kinase and methods of treatment of bone destruction due to cancer or other conditions utilizing the provided phosphonate conjugates.
PHOSPHONATE DERIVATIVES OF LIPOPHILIC AMINES
-
, (2008/06/13)
This invention relates to a class of novel phosphonate derivatives of lipophilic amines which exhibit squalene synthase inhibition properties. More specifically the compounds are bis aryl cycloalkylamino and azacycloalkyl phosphonates. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.
